BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2596063)

  • 1. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
    Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
    Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of the immune system in benign lesions and cancer of the breast].
    Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
    Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic sampling analysis of the immune status of breast cancer patients].
    Eremina OF; Kunitsyna TA; Sharonina AI
    Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
    Kupin VI; Polevaia EB
    Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
    Fedin IuV; Ermilova VD
    Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumours.
    Byrom NA; Retsas S; Dean AJ; Hobbs JR
    Clin Oncol; 1978 Mar; 4(1):25-34. PubMed ID: 305835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonal and immunological changes in breast cancers with different growth rates].
    Balmukhanov SB; Zhalgasbaeva GT; Kurralasov AK; Baisheva SA; Togaĭbaeva ZI
    Vopr Onkol; 1989; 35(11):1319-22. PubMed ID: 2609521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B lymphocytes in cancer patients.
    Sengupta U; Dutta TK; Gupta BD; Aikat BK
    Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA; Drannik GN; Nikol'skiĭ IS; Kalinina NA; Litvishchenko EI
    Vopr Onkol; 1984; 30(12):23-7. PubMed ID: 6240157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative morphological characteristics of the changes in the effector component of the immune system in dyshormonal hyperplasias and breast cancer].
    Abrakova EL
    Vopr Onkol; 1982; 28(10):81-5. PubMed ID: 7147824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN; Galstian AM; Ovanesbekova TG; Ter-Pogosian ZR; Kuznetsov VP
    Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative characteristics of the immunologic indicators in patients with prostatic adenoma and cancer].
    Savinov VA; Khalezov SP; Sviridova AM
    Urol Nefrol (Mosk); 1983; (2):17-20. PubMed ID: 6190286
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophyseal hormones in young patients with breast cancer].
    Chobanian NS; Kushlinskiĭ NE; Bassalyk LS; Kuzmina ZV; Gershteĭn ES; Saveléva EV; Baryshnikov AIu; Kadagidze ZG
    Klin Med (Mosk); 1994; 72(3):37-40. PubMed ID: 7990352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
    Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.